|
× |
 |
How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example PDF |
$40.00 |
|
$40.00 |
|
× |
|
Factors That Impact Treatment Decisions: Results From an Online Survey of Individuals With Bipolar and Unipolar Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone PDF |
$40.00 |
|
$40.00 |
|
× |
|
Adjunctive Aripiprazole in Major Depressive Disorder: Analysis of Efficacy and Safety in Patients With Anxious and Atypical Features PDF |
$40.00 |
|
$40.00 |
|
× |
|
Two Instances of Improvement in Tardive Dyskinesia After Administration of Aripiprazole in a Single Patient PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prenatal Exposure to Acetaminophen and the Risk of Attention-Deficit/Hyperactivity Disorder: A Nationwide Study in Taiwan PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Alcohol Use Disorder PDF |
$40.00 |
|
$40.00 |
|
|
